Affordable Access

Preoperative TNM-classification is a better prognostic indicator for recurrence of hepatocellular carcinoma after liver transplantation than albumin mRNA in peripheral blood. Liver Transplant Oncology Group.

Authors
  • Peck-Radosavljevic, M1
  • Pidlich, J
  • Bergmann, M
  • Ferenci, P
  • Seelos, C
  • Wichlas, M
  • Lipinski, E
  • Gnant, M
  • Gangl, A
  • Mühlbacher, F
  • 1 Department of Gastroenterology and Hepatology, University of Vienna, Austria. [email protected] , (Austria)
Type
Published Article
Journal
Journal of Hepatology
Publisher
Elsevier
Publication Date
Mar 01, 1998
Volume
28
Issue
3
Pages
497–503
Identifiers
PMID: 9551689
Source
Medline
License
Unknown

Abstract

Detection of albumin mRNA in peripheral blood by reverse transcription-polymerase chain reaction seems to be an unreliable marker for assessing hematogenous spread of hepatocellular carcinoma. With International Union against Cancer stage IV A being a much better predictor of tumor recurrence, the practical value of albumin mRNA reverse transcription-polymerase chain reaction for patient selection in liver transplant candidates seems to be very limited.

Report this publication

Statistics

Seen <100 times